Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Data from Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 Versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer

Carsten Denkert,Chiara Lambertini,Peter A. Fasching,Katherine L. Pogue-Geile,Max S. Mano,Michael Untch,Norman Wolmark,Chiun-Sheng Huang,Sibylle Loibl,Eleftherios P. Mamounas,Charles E. Geyer Jr,Peter C. Lucas,Thomas Boulet,Chunyan Song,Gail D. Lewis,Malgorzata Nowicka,Sanne de Haas,Mark Basik

Clinical Cancer Research（2023）

Cited 38|Views73

Key words

Neoadjuvant Therapy,Trastuzumab,Breast Cancer,Treatment Response

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined